208 related articles for article (PubMed ID: 30864100)
1. Progressive multifocal leukoencephalopathy treated with nivolumab.
Hoang E; Bartlett NL; Goyal MS; Schmidt RE; Clifford DB
J Neurovirol; 2019 Apr; 25(2):284-287. PubMed ID: 30864100
[TBL] [Abstract][Full Text] [Related]
2. Progressive Multifocal Leukoencephalopathy after Treatment with Nivolumab.
Martinot M; Ahle G; Petrosyan I; Martinez C; Gorun DM; Mohseni-Zadeh M; Fafi-Kremer S; Tebacher-Alt M
Emerg Infect Dis; 2018 Aug; 24(8):1594-1596. PubMed ID: 30016251
[TBL] [Abstract][Full Text] [Related]
3. Effectiveness of Immune Checkpoint Inhibitors in Transplant Recipients with Progressive Multifocal Leukoencephalopathy.
Medrano C; Vergez F; Mengelle C; Faguer S; Kamar N; Del Bello A
Emerg Infect Dis; 2019 Nov; 25(11):2145-2147. PubMed ID: 31625858
[TBL] [Abstract][Full Text] [Related]
4. Progressive multifocal leukoencephalopathy associated with a lymphoproliferative disorder treated with pembrolizumab.
Holmes A; Wellings T; Walsh O; Rowlings P
J Neurovirol; 2020 Dec; 26(6):961-963. PubMed ID: 32910430
[TBL] [Abstract][Full Text] [Related]
5. Pembrolizumab Treatment for Progressive Multifocal Leukoencephalopathy.
Cortese I; Muranski P; Enose-Akahata Y; Ha SK; Smith B; Monaco M; Ryschkewitsch C; Major EO; Ohayon J; Schindler MK; Beck E; Reoma LB; Jacobson S; Reich DS; Nath A
N Engl J Med; 2019 Apr; 380(17):1597-1605. PubMed ID: 30969503
[TBL] [Abstract][Full Text] [Related]
6. Novel treatments for progressive multifocal leukoencephalopathy.
Bennett KM; Fernandes PM
Br J Hosp Med (Lond); 2020 Jul; 81(7):1-9. PubMed ID: 32730143
[TBL] [Abstract][Full Text] [Related]
7. Progressive multifocal leukoencephalopathy and immune reconstitution inflammatory syndrome (IRIS).
Bauer J; Gold R; Adams O; Lassmann H
Acta Neuropathol; 2015 Dec; 130(6):751-64. PubMed ID: 26323992
[TBL] [Abstract][Full Text] [Related]
8. Treatment of Progressive Multifocal Leukoencephalopathy with Nivolumab.
Walter O; Treiner E; Bonneville F; Mengelle C; Vergez F; Lerebours F; Delobel P; Liblau R; Martin-Blondel G;
N Engl J Med; 2019 Apr; 380(17):1674-1676. PubMed ID: 30969500
[No Abstract] [Full Text] [Related]
9. Progressive multifocal leukoencephalopathy: new concepts.
Lima MA
Arq Neuropsiquiatr; 2013 Sep; 71(9B):699-702. PubMed ID: 24141508
[TBL] [Abstract][Full Text] [Related]
10. Checkpoint inhibitors for the treatment of JC virus-related progressive multifocal leukoencephalopathy.
Beck ES; Cortese I
Curr Opin Virol; 2020 Feb; 40():19-27. PubMed ID: 32279025
[TBL] [Abstract][Full Text] [Related]
11. Epilepsia partialis continua revealing idelalisib-associated PML-IRIS: clinical and pathological features.
Vogrig A; Gigli GL; Nilo A; Pessa ME; Volpetti S; Pegolo E; Valente M
J Neurovirol; 2020 Jun; 26(3):437-441. PubMed ID: 31807988
[TBL] [Abstract][Full Text] [Related]
12. PML-IRIS in patients with HIV infection: clinical manifestations and treatment with steroids.
Tan K; Roda R; Ostrow L; McArthur J; Nath A
Neurology; 2009 Apr; 72(17):1458-64. PubMed ID: 19129505
[TBL] [Abstract][Full Text] [Related]
13. Update on progressive multifocal leukoencephalopathy.
Steiner I; Berger JR
Curr Neurol Neurosci Rep; 2012 Dec; 12(6):680-6. PubMed ID: 22991070
[TBL] [Abstract][Full Text] [Related]
14. Immune checkpoint inhibitors for progressive multifocal leukoencephalopathy: a new gold standard?
Roos-Weil D; Weiss N; Guihot A; Uzunov M; Bellanger A; Eymard B; Saadoun D; Houillier C; Idbaih A; Demeret S; Deback C; Leblond V; Galanaud D; Shor N; Pourcher V
J Neurol; 2021 Jul; 268(7):2458-2465. PubMed ID: 33515299
[TBL] [Abstract][Full Text] [Related]
15. JC Polyomavirus, progressive multifocal leukoencephalopathy and immune reconstitution inflammatory syndrome: a review.
Harypursat V; Zhou Y; Tang S; Chen Y
AIDS Res Ther; 2020 Jul; 17(1):37. PubMed ID: 32631361
[TBL] [Abstract][Full Text] [Related]
16. HIV-associated progressive multifocal leukoencephalopathy: longitudinal study of JC virus non-coding control region rearrangements and host immunity.
Iannetta M; Bellizzi A; Lo Menzo S; Anzivino E; D'Abramo A; Oliva A; D'Agostino C; d'Ettorre G; Pietropaolo V; Vullo V; Ciardi MR
J Neurovirol; 2013 Jun; 19(3):274-9. PubMed ID: 23715894
[TBL] [Abstract][Full Text] [Related]
17. The Effect of Intravenous Methylprednisolone on Recurrent Exacerbation in Hematologic Malignancy-associated Progressive Multifocal Leukoencephalopathy.
Nakamura R; Kitamura A; Tsukamoto T; Tamura R; Ogawa N; Yamakawa I; Kim H; Kawai M; Sanada M; Urushitani M
Intern Med; 2021 Apr; 60(8):1287-1291. PubMed ID: 33229808
[TBL] [Abstract][Full Text] [Related]
18. A Chronic Lymphocytic Leukemia Patient with Progressive Multifocal Leukoencephalopathy Caused by John Cunningham Virus.
Ramadhani P; Bramantono B; Sedana MP
Acta Med Indones; 2018 Apr; 50(2):151-158. PubMed ID: 29950535
[TBL] [Abstract][Full Text] [Related]
19. Progressive multifocal leukoencephalopathy.
Aksamit AJ
Continuum (Minneap Minn); 2012 Dec; 18(6 Infectious Disease):1374-91. PubMed ID: 23221846
[TBL] [Abstract][Full Text] [Related]
20. Postallogeneic transplantation progressive multifocal leukoencephalopathy successfully treated by nivolumab.
Uzunov M; Demeret S; Nguyen-Quoc S; Morel V; Bellanger A; Chavez H; Gasnault J; Leblond V; Roos-Weil D
Br J Haematol; 2020 Mar; 188(6):e82-e84. PubMed ID: 31797364
[No Abstract] [Full Text] [Related]
[Next] [New Search]
